Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review-Reference-Cited by-同舟云学术

Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review

Published:2023-03 Issue: Volume:114 Page:102511
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Miglietta F.,Fabi A.,Generali D.,Dieci M.V.,Arpino G.,Bianchini G.,Cinieri S.,Conte P.F.,Curigliano G.,De Laurentiis M.,Del Mastro L.,De Placido S.,Gennari A.,Puglisi F.,Zambelli A.,Perrone F.,Guarneri V.

Funder

Gilead Sciences

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference40 articles.

1. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update;Allison;J Clin Oncol,2020

2. ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer;Gennari;Ann Oncol,2021

3. Pattern of metastatic spread in triple-negative breast cancer;Dent;Breast Cancer Res Treat,2009

4. Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence;Dent;Clin Cancer Res,2007

5. Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer;Liedtke;J Clin Oncol,2008

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical review;Cancer Treatment Reviews;2024-11

2. Genomic characterization reveals distinct mutational landscapes and therapeutic implications between different molecular subtypes of triple-negative breast cancer;Scientific Reports;2024-05-29

3. Cell Line-Dependent Adhesion and Inhibition of Proliferation on Carbon-Based Nanofilms;Nanotechnology, Science and Applications;2023-12

4. Tumor Infiltrating Lymphocytes (TILS) and PD-L1 Expression in Breast Cancer: A Review of Current Evidence and Prognostic Implications from Pathologist’s Perspective;Cancers;2023-09-08

5. Suppressing Src-Mediated EGFR Signaling by Sustained Calcium Supply Targeting Triple-Negative Breast Cancer;International Journal of Molecular Sciences;2023-08-27